NANOCO GROUP PLC — Regulatory Filings 2018

Sep 11, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9962Z

Nanoco Group PLC

11 September 2018

11 September 2018

NANOCO GROUP PLC

("Nanoco" or the "Company")

Investor day

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nano-materials, will today be hosting an investor day at its offices in Manchester and its recently expanded facility in Runcorn.

No new material information will be disclosed during the day.

Presentations from the day will be made available at http://www.nanocotechnologies.com/investor-relations.

- Ends -

For further information, please contact:

Nanoco
Caroline Watson, Investor Relations Manager	Tel: + 44 (0) 7799 897357
cwatson@nanocotechnologies.com
MHP Communications	Tel: +44 (0) 20 3128 8570
Reg Hoare / Giles Robinson / Pete Lambie nanoco@mhpc.com

Notes for editors:

About Nanoco Group plc

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications including LCD display, lighting, healthcare, nano-materials and solar.

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany and Wah Hong Industrial Corporation of Taiwan.

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition.

Nanoco is listed on the Main Market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com. 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUGUWWBUPRUBQ